Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: a 31P MRS study by Bawden, Stephen et al.
1 
 
TITLE 1 
Investigating the effects of an Oral Fructose Challenge on Hepatic ATP Reserves in 2 
Healthy Volunteers: A 31P MRS Study 3 
AUTHORS 4 
S. J. Bawden1,a, M. C. Stephenson1,a, E. Ciampib, K. Hunterb, L. Marcianic, I. A. 5 
Macdonaldd,  G. P. Aithalc, P. G. Morrisa, P. A. Gowlanda 6 
1 Joint first authors 7 
a Sir Peter Manfield Imaging Centre, University of Nottingham, Nottingham, UK 8 
bUnilever Discover, Unilever, Colworth, UK 9 
cNIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University  10 
Hospitals NHS Trust and University of Nottingham, Nottingham, UK 11 
dSchool of Life Sciences, University of Nottingham, Nottingham, UK 12 
 13 
DEPARTMENT AND INSTITUTION OF STUDY 14 
All work was conducted at the Sir Peter Mansfield Imaging Centre in the University of 15 
Nottingham, UK 16 
 17 
CORROSPONDING AUTHOR 18 
Dr. Stephen Bawden 19 
SPMIC, University Park, University of Nottingham, NG7 2RD 20 
Tel: +44 (0) 115 951 4747; Fax: +44 (0) 0115 951 5166  21 
stephen.bawden@nottingham.ac.uk 22 
 23 
Field Code Changed
2 
 
ARTICLE ELECTRONIC WORD COUNT 24 
3,047 (without references) 25 
 26 
FIGURE AND TABLES 27 
Number of Figures: 4 28 
Number of Tables: 0 29 
 30 
LIST OF ABBREVIATIONS  31 
NAFLD – Non-Alcoholic Fatty Liver Disease 32 
NASH – Non-Alcoholic Steatohepatitis 33 
ATP – Adenosine Triphosphate 34 
MRS – Magnetic Resonance Spectroscopy 35 
Pi – Inorganic Phosphate 36 
PDE – Phosphodiesters 37 
PME – Phosphomonoesters 38 
IV – Intravenous 39 
ISIS – Image Selective In vivo Spectroscopy 40 
NOE – Nuclear Overhouser Effect 41 
SD – Standard Deviation 42 
ADP – Adenosine Diphosphate 43 
AMP – Adenosine Monophosphate 44 
AMPK – AMP-activated protein kinase 45 
UTP – Uridine Triphosphate 46 
 47 
KEYWORDS 48 
3 
 
ATP; hepatic ATP; fructose; fructose infusion; oral challenge; NAFLD; 31P; MRS 49 
 50 
CONFLICT OF INTEREST 51 
The first author is part of an industrial collaborative award in science and engineering 52 
(CASE) studentship funded jointly by the Biotechnology and Biological Sciences Research 53 
Council (BBRSC) and Unilever.  54 
 55 
FINANCIAL SUPPORT 56 
This work has been funded jointly by the BBRSC and Unilever 57 
 58 
AUTHORS CONTRIBUTIONS 59 
Study conception and design: SB; MS; LM; GA; PM; PG;  60 
Acquisition of data: SB; MS 61 
Analysis and interpretation of data: SB; MS; GA; IM; LM; PG 62 
Drafting of manuscript: SB 63 
Critical revision: SB; MS; EC; KH; LM; IM; GA; PM; PG 64 
 65 
 66 
  67 
4 
 
ABSTRACT 68 
Background: Impaired homeostasis of hepatic ATP has been associated with NAFLD. An 69 
intravenous fructose infusion has been shown to be an effective challenge to monitor the 70 
depletion and subsequent recovery of hepatic ATP reserves using 31P MRS. 71 
Aims: The purpose of this study was to evaluate the effects of an oral rather than intravenous 72 
fructose challenge on hepatic ATP reserves in healthy subjects. 73 
Methods: Self-reported healthy males were recruited. Following an overnight fast, baseline 74 
liver glycogen and lipid levels were measured using Magnetic Resonance Spectroscopy 75 
(MRS). Immediately after consuming a 500ml 75g fructose drink (1275 kJ) subjects were 76 
scanned continuously for 90 minutes to acquire dynamic 31P MRS measurements of liver 77 
ATP reserves.  78 
Results: A significant effect on ATP reserves was observed across the time course (P < 79 
0.05). Mean ATP levels reached a minimum at 50 minutes which was markedly lower than 80 
baseline (80 ± 17% baseline, P < 0.05). Subsequently, mean values tended to rise but did not 81 
reach statistical significance above minimum. The time to minimum ATP levels across 82 
subjects was negatively correlated with BMI (R2=0.74, P < 0.005). Rates of ATP recovery 83 
were not significantly correlated with BMI or liver fat levels, but were negatively correlated 84 
with baseline glycogen levels (R2=0.7, P<0.05).  85 
Conclusions:  Depletion of ATP reserves can be measured non-invasively following an oral 86 
fructose challenge using 31P MRS. BMI is the best predictor of postprandial ATP homeostasis 87 
following fructose consumption. 88 
 89 
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INTRODUCTION 91 
Both NAFLD and non-alcoholic steatohepatitis (NASH) have been associated with impaired 92 
homeostasis of hepatic adenosine triphosphate (ATP) levels [1] and baseline hepatic ATP 93 
reserves have been shown to be more depleted in obese subjects [2, 3]. It is widely accepted 94 
that the inhibition of AMP-activate protein kinase (AMPK) which stimulates ATP synthesis 95 
is an important part of liver lipid accumulation [4, 5] and it has also been suggested that an 96 
inability to maintain ATP levels may prime hepatocytes to become vulnerable to injury by 97 
reactive oxygen species. 98 
Hepatic ATP reserves can be monitored noninvasively using 31P magnetic resonance 99 
spectroscopy (MRS) [6]. Early animal studies used this method to monitor ATP following 100 
fructose injections and suggested its potential use as a diagnostic method for studying liver 101 
disease [7]. A number of more recent studies have used these techniques to measure ATP 102 
homeostasis following an intravenous (IV) fructose load [2, 8, 9]. Fructose infusion causes 103 
the  depletion of hepatic ATP levels due to a lack of phosphorylation feedback which results 104 
in continued phosphorylation activating AMP deaminase and uric acid production 105 
(supplementary material) [10]. During these studies, subjects undergo continuous 31P MRS 106 
immediately following a fructose bolus injection to measure minimum ATP levels and 107 
subsequent rates of replenishment.  108 
The effects of fructose consumption on liver lipids [11] and NASH [12] have been considered 109 
in the literature, but little research has investigated the immediate ATP response to an oral 110 
fructose challenge. The present study investigated postprandial changes to hepatic ATP 111 
reserves following an oral fructose intake. 112 
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MATERIAL AND METHODS 114 
Subjects 115 
All subjects were self-reported healthy non-obese males with sedentary lifestyles and no 116 
known metabolic disorders. All subjects consumed the oral challenge in the time required (5 117 
minutes) and complied well with the lifestyle restrictions and scanning requirements. The 118 
mean age for all subjects was 24 ± 4 years and BMI was 25 ± 3 kg/m2. 119 
Study Design 120 
Ethical Permission 121 
Ethical permission was obtained from the local Medical School Research Ethics Committee 122 
and subjects provided written informed consent before participation.  123 
Subjects 124 
At the time of this investigation there were no published data on 31P MRS ATP following an 125 
oral fructose challenge which could be used to estimate the power of the study. We therefore 126 
chose a sample size for this first exploratory study based on data reported in infusion studies 127 
[13, n=8]. 128 
Prior to study days subjects were asked to refrain from alcohol for 24hr. On the morning of 129 
the study subjects arrived at the test centre between 7:30am and 8:00am having fasted 130 
overnight. 131 
On arrival, natural abundance 13C MR spectra were acquired from the liver to determine 132 
baseline hepatic glycogen levels, and localized 1H MR spectra were acquired to determine 133 
baseline hepatic lipid levels. Subjects were then asked to consume a 500ml drink of 75g 134 
fructose solution (1275 kJ) within 5 minutes. Immediately following consumption, subjects 135 
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were placed in the scanner and 31P MR spectra were acquired continuously for 90 minutes to 136 
assess dynamic changes in ATP and related phosphate metabolites. During the 90 minutes of 137 
scanning, subjects were asked to breathe regularly and remain as still as possible and were 138 
allowed to listen to the radio or music. 139 
Data Acquisition 140 
All measurements were performed on a Philips Achieva 3T system (Philips, Best, The 141 
Netherlands) using the built-in 1H transmit / receive body coil for scout images and voxel 142 
placement.  143 
ATP  144 
Dynamic changes in phosphate metabolites were measured using localized 31P MRS. A 31P 145 
surface coil (Philips, Best, The Netherlands) was placed on the abdomen over the liver. Scout 146 
1H images were obtained and used for voxel placement in the right lobe of the liver (60 x 60 147 
x 60 mm3 voxel size). 31P spectra were obtained continuously for 90 minutes using a 148 
respiratory triggered ISIS sequence with Nuclear Overhouser Effect (NOE) enhancement and 149 
proton decoupling (3 kHz bandwidth, 2048 samples, 5000 ms repetition time) as described 150 
previously [14, 15]. The voxel for β-ATP was positioned against the abdominal wall with the 151 
chemical shift of all other metabolites directed away from the wall to minimize signal leakage 152 
from the abdominal muscle (confirmed by a lack of spectral PCr peak) and maximise signal 153 
for β-ATP.  154 
Hepatic Lipids 155 
Baseline lipid levels were measured using the integrated 1H body coil. Scout images were 156 
obtained and used for voxel placement (30 x 30 x 30 mm3 voxel size). 1H spectra were 157 
obtained using a respiratory triggered, water suppressed STEAM sequence (2 kHz 158 
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bandwidth, 1024 samples, 13 ms echo time, 5000 ms repetition time, 40 averages). Two 159 
spectra were collected without water suppression for correction to absolute lipid fat fractions 160 
as described previously [15]. 161 
Glycogen 162 
Baseline glycogen levels were measured using unlocalized 13C MRS. A surface coil with 163 
integrated quadrature proton decoupling (PulseTeq, Surrey, UK) was placed on the abdomen 164 
over the liver. Scout 1H images were used to determine correct placement. 13C spectra were 165 
obtained using a π/2 pulse-acquire sequence with an adiabatic half passage pulse shape to 166 
minimise the effects of B1 field inhomogeneity within the volume of interest, along with 167 
narrow band proton decoupling (7 kHz bandwidth, 512 samples, 2150 ms repetition time, 576 168 
averages, ~20 minutes total acquisition time) as previously described [16]. 169 
MRS analysis 170 
ATP  171 
31P spectra were line broadening by 30 Hz and data were averaged over 15 minute windows 172 
at 5 minutes intervals across the time-course. The β-ATP peak position was defined in the 173 
spectra and peak area calculated across the time course (Figure1). The β-ATP peak provides a 174 
way of measuring total ATP because the phosphate signal from ADP overlaps with the α-175 
ATP and γ-ATP peaks. The first time point was taken as a reference to measure changes in 176 
ATP and recorded as % of baseline value.  177 
Time to reach minimum ATP levels was calculated, and the rate of recovery of absolute ATP 178 
was determined using the gradient across the first 4 time points of recovery using linear 179 
fitting. For recovery rates, ratios of β-ATP to total phosphorous levels were taken as used in 180 
previous studies [3]. 181 
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Hepatic Lipids 182 
1H spectra were zero filled to 1024 datapoints and phase corrected before peak areas were 183 
calculated using the AMARES algorithm in jMRUI (Universiteit Leuven, Belgium) [17] 184 
(Lorentzian curve fitting of water peak at ~4.8ppm and -[CH2]n- at ~1.3 ppm). Water 185 
suppression was applied during spectral acquisition for better resolution of the fat peak, 186 
followed by unsuppressed spectra with identical parameters to determine the water peak area. 187 
Peak areas were corrected for T2 relaxation as determined from previous studies and 188 
lipid/water ratios used to determine absolute fat fractions as described by Stephenson et al 189 
[23].  190 
Glycogen 191 
13C spectra were zero filled to 4096 datapoints and 100 Hz line broadening was applied 192 
before Lorentzian curve fitting using in house software. Integrals of the C1-glycogen peak 193 
(100.4 ppm) and of an external reference peak were measured and ratios used to account for 194 
varying loading factors. Quantification was achieved by comparing glycogen/reference ratios 195 
with a phantom [18].  196 
Statistical Analysis 197 
All results are expressed as means (±SD). A repeated measures ANOVA F-test was used to 198 
determine a significant effect across the timecourse, and a means difference T-tests were 199 
subsequently used on individual time points to determine significant changes. Significances 200 
in correlations were determined using linear regression analysis with Pearson correlation 201 
coefficients quoted. In all cases significance was attributed to P < 0.05. The statistical 202 
package used for analysis was SPSS version 21 for Windows (SPSS, Inc., Chicago, IL). 203 
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RESULTS 205 
Baseline Hepatic Lipid and Glycogen 206 
The mean baseline liver lipid fat fraction was 4 ± 3 % and correlated significantly with BMI 207 
(R2 = 0.48, P ≤ 0.05) as expected.  208 
The mean baseline hepatic glycogen concentration was 219 ± 81 mmol/l and there were no 209 
correlations between individual values and age, BMI or baseline liver lipid levels. 210 
ATP Reserves following Oral Fructose Challenge 211 
Mean postprandial hepatic ATP levels began to decline from 15 minutes after the oral 212 
fructose challenge (Figure 2). A statistically significant variation from baseline was found 213 
across the time course (One way ANOVA F-test, P < 0.05). Mean values continued to decline 214 
and were significantly below the first two points at t = 30 minutes (86 ± 14%, P < 0.05), t = 215 
40 minutes (85 ± 16 %. P < 0.05) and t = 45 minutes (84 ± 14%, P < 0.005) until reaching 216 
minimum at = 50 minutes (80 ± 17%, P < 0.05). There was a trend for values to recover after 217 
50 minutes, but the increase was not statistical significance compared to nadir and levels 218 
remained lower than baseline at the end of the study. 219 
No subject showed any recovery of ATP levels during the first 6 time points (until t = 40 220 
mins). The mean AUC across this period (t=0 to t=40 mins) was 232 ± 19 % h and showed a 221 
strong negative correlation with BMI (R2 = 0.65, P < 0.01).  222 
Time to minimum ATP 223 
For two subjects the minimum ATP time point was at the end of the scanning period, and as 224 
such the final time point was taken as their time to minimum ATP (which may in fact have 225 
been after the scan period). A significant negative correlation was found between time to 226 
11 
 
minimum ATP and BMI (R2 = 0.74, P < 0.005) as shown in Figure 3. No such correlation 227 
was observed with age (R2 = 0.01, P = 0.78) or baseline glycogen (R2 = 0.003, P = 0.88) but 228 
the correlation approached significance with baseline liver fat (R2 = 0.39, P = 0.07).  229 
Rate of recovery 230 
Figure 4 shows the relationship between rate of recovery and baseline glycogen reserves, 231 
which had a strong negative correlation that was statistically significant (R2 = 0.71, P < 0.05). 232 
This correlation was not observed with BMI, liver fat, or any other baseline measures.  233 
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DISCUSSION 235 
The underlying physiological hypothesis of this study is that ATP homeostasis, which 236 
provides a measure of AMPK activity, acts as a biomarker for NAFLD and NASH. Rather 237 
than fructose infusion, this study explored using 31P MRS following an oral fructose 238 
challenge, which is more physiological, more patient-acceptable and much simpler to 239 
administer. The results showed that after oral consumption there is a measurable decline in 240 
ATP reserves (β-ATP) followed by a partial recovery. This observation is characteristic of 241 
fructose metabolism and can be explained as a result of the immediate rapid phosphorylation 242 
of the monosaccharide. Under normal physiological conditions an increased cellular level of 243 
adenosine monophosphate (AMP) activates AMPK resulting in the regeneration of ATP, 244 
whereas under conditions where AMPK activity is lower (e.g. following fructose 245 
consumption) the production of uric acid is favoured over ATP (supplementary material). In 246 
addition to this, fructose has been shown to up-regulate Glut5 and Fructokinase [19], and 247 
subjects with NAFLD and a higher intake of fructose have been shown to have a greater 248 
hepatic mRNA expression of fructokinase [20].  249 
In a small study of 4 subjects Buemann et al. tested the effects of an oral dose of 30g D-250 
Fructose and D-Tagatose on hepatic ATP reserves at 1.5T [21] and reported no drop in ATP 251 
following D-fructose consumption (however, they did find a drop following D-Tagatose 252 
which reached a maximum at 51 minutes). The data from the present study suggests that a 253 
greater concentration of fructose and high resolution spectra (3T scanner) may be required to 254 
observe significant reductions.  255 
In the present study ATP levels took longer to recover compared to previous infusion studies. 256 
This is probably due to the extra stages necessary to transfer fructose to the hepatic tissue, 257 
namely gastric emptying and intestinal absorption. Gastric emptying has been shown to be 258 
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dependent on meal energy and volume [22], which becomes relevant to the techniques used 259 
here when considering the optimum energy content and volume of the fructose challenge to 260 
induce sufficient depletion of hepatic ATP. Another confounding factor is the variation in 261 
fructose intestinal absorption rates reported in the literature. A previous study showed a high 262 
variability in intestinal absorption of fructose in healthy subjects following an oral fructose 263 
drink [23]. The amount of fructose used in the present study was sufficient for intestinal 264 
absorption and delivery to the liver in all subjects, but this factor should be considered in 265 
future experiments, and it may be that lower doses and volumes of fructose will not have the 266 
same effect.  267 
This study showed a negative correlation between BMI and time to minimum ATP levels. 268 
Given that the hepatic ATP response is a combination of depletion and recovery and fructose 269 
is known to deplete ATP reserves, these findings suggest that individuals with lower BMI 270 
have a more effective hepatic ATP recovery in response to a high fructose challenge. This 271 
result may be confounded by changes in gastrointestinal function, but also confirms previous 272 
studies that have shown that obese subjects have an impaired efficiency of ATP 273 
replenishment [2]. Surprisingly this correlation was not observed with liver fat levels as 274 
might be expected. Previous studies have shown that there is an impaired hepatic ATP 275 
homeostasis in Type2 diabetes [24] and it has been suggested that this may precede the 276 
development of steatosis in these patients [3]. Whether or not there is a causal link between 277 
rates of ATP synthesis and metabolic disorders remains to be established. Related to this, it 278 
has been suggested that regular consumption of fructose upregulates fructokinase and that 279 
this may be a factor in NAFLD development and the high incident rates observed currently 280 
[20]. In the present study we did not acquire a full dietary history, but future studies in this 281 
area should explore the effects of prior exposure and its relevance to ATP depletion and 282 
recovery rates and steatosis. 283 
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This experiment required 2 hours of scanning on a high field MRI scanner , which may be 284 
impractical and costly in a clinical setting. However, it is possible that other related measures 285 
may provide a more convenient marker. For example, there was a significant negative 286 
correlation between the AUC over the first 6 time points and BMI. These measures can be 287 
made over a shorter scan duration. Future studies should consider a wider range of liver fat, 288 
as well as NAFLD and NASH patients. In particular, studies that separate BMI from liver fat 289 
to determine which of these is a better predictor of ATP homeostasis, although admittedly it 290 
would be difficult to recruit for this given the correlation between BMI and liver fat. 291 
Baseline glycogen measurements gave a wide range of values, which suggests variability in 292 
the timing and content of the previous evening meal across subjects [16]. Whilst this may 293 
reveal a potential limitation in the study design, the results showed for the first time a 294 
significant negative correlation between rates of ATP synthesis and baseline glycogen levels 295 
which may be relevant to patients with glycogen storage disease and other metabolic 296 
disorders. Previous studies have shown that a fructose load activates glycogen synthase 297 
resulting in increased glycogenesis, and also that fructose-1-phosphate produced during 298 
fructose metabolism is a competitive inhibitor of phosphorylase a [25] resulting in a slowed 299 
glycogenolysis. These factors result in an increase in glycogen synthesis following fructose 300 
consumption. The relationship between glycogen levels and ATP reserves has been explored 301 
in a number of publications and correlations between glycogen synthesis and ATP turnover in 302 
muscle [26] and between absolute hepatic glycogen levels and total hepatic ATP content 303 
during glycogen repletion [27] have been reported. This has been explained as the need for 304 
increased uridine triphosphate (UTP) during periods when unidirectional flux of glycogen 305 
synthesis is greater than glycogenolysis, which results in greater ATP synthesis. A possible 306 
explanation for the negative correlations between rates of ATP synthesis and baseline 307 
glycogen levels observed in the present study is that there is a greater demand from hepatic 308 
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glycogen in subjects with lower baseline glycogen levels, resulting in an increased rate of 309 
glycogen synthesis and indirectly ATP synthesis. Whilst it is beyond the scope of this study 310 
to determine this causal link, this study shows that baseline hepatic glycogen levels are an 311 
important factor in the ATP response to fructose.  312 
The present study has some limitations. Firstly, breath samples were not obtained to estimate 313 
levels of intestinal fructose malabsorption [28]. Measuring changes in serum uric acid  would 314 
also be ideal as hyperuricemia has been associated with an impaired hepatic ATP 315 
homeostasis in response to high fructose intake [3]. Future experiments should obtain blood 316 
samples to measure this also. Secondly, histological comparisons were not made due to the 317 
ethical considerations of liver biopsies in healthy subjects. As such, although all subjects in 318 
this study had no known liver health problems this was not confirmed through histological 319 
analysis. Other studies should investigate the postprandial ATP effects in patients with 320 
NASH in comparison with healthy weight and obese people, as well as individuals with Type 321 
2 diabetes. Similarly, all subjects in this study were healthy non-obese male volunteers and it 322 
should be acknowledged that the response may be different in women or an obese cohort. 323 
Subjects also found 500 ml fluid difficult to consume and the scan time was long and 324 
potentially uncomfortable. Future studies should optimize the experimental protocol, in 325 
particular the time duration, time resolution and volume or concentration of fructose 326 
challenge used.  327 
In summary, this study has shown that depletion in hepatic ATP reserves following an oral 328 
fructose challenge is observable using 31P MRS in healthy subjects, allowing for a completely 329 
non-invasive assessment of ATP synthesis. BMI was negatively correlated with the time to 330 
minimum ATP levels and with ATP levels immediately post consumption   indicating an 331 
impaired hepatic energy homeostasis in subjects with higher BMI.  332 
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